Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,139 | -476 | -1,438 | -1,111 | -898 |
| Depreciation Amortization | 52 | 53 | -189 | 22 | 15 |
| Accounts receivable | -1 | -7 | 4 | 2 | 1 |
| Other Working Capital | 162 | 93 | 94 | -14 | -7 |
| Other Operating Activity | 151 | 67 | 290 | 215 | 157 |
| Operating Cash Flow | $-774 | $-270 | $-1,240 | $-886 | $-732 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -7 | -2 | -2 |
| Purchase Sale Intangibles | -250 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -250 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-251 | $-1 | $-7 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,200 | 575 | 695 | 340 | 300 |
| Debt Repayment | -12 | -5 | N/A | N/A | N/A |
| Financing Cash Flow | $1,188 | $570 | $695 | $340 | $300 |
| Beginning Cash Position | 10 | 10 | 561 | 561 | 561 |
| End Cash Position | 173 | 308 | 10 | 14 | 127 |
| Net Cash Flow | $163 | $298 | $-552 | $-547 | $-434 |
| Free Cash Flow | |||||
| Operating Cash Flow | -774 | -270 | -1,240 | -886 | -732 |
| Capital Expenditure | -1 | -1 | -7 | -2 | -2 |
| Free Cash Flow | -775 | -272 | -1,247 | -887 | -734 |